News & Opinions Home
Market Place
Busiwire
Research and Markets: Malaysia's Pharmaceutical Market Report Estimates the Malaysian Market to Stand at US$1,072 Million in 2009
Thursday June 18, 02:00 PM
Research and Markets (http://www.researchandmarkets.com/research/b4283a/the_pharmaceutical)
has announced the addition of the "The
Pharmaceutical Market: Malaysia" report to their offering.
The government is keen to encourage the local production of drugs,
particularly in the fields of biotechnology and the manufacture of
off-patent drugs. Several incentives have been put in place, including
tax exemptions for biotech companies that are awarded Bionexus status.
By the end of 2008, there were a total 92 companies with Bionexus
status, of which 36 focused on healthcare. This was a rise of 119% over
the 2007 total of 42 companies; the number of healthcare biotech
companies rose 89.5% over the same period from just 19 previously.
Malaysia's biotech initiative has begun to attract a growing number of
multinational companies investing in the country, there have been rising
new and ongoing investments in manufacturing plants and research
projects in recent times. Local manufacturers almost exclusively produce
generics and other off-patent medicaments, both ethical and OTC
products, but imported medicines by multinational manufacturers still
command the lion's share of the market, at over 70% in value terms.
We estimate the Malaysian market to stand at US$1,072 million in 2009,
and reach US$1.6 billion in 2014, growing at an impressive average rate
of around 8.2% per annum. Per capita spending is expected to grow from
US$38 to US$52.
These in-depth pharmaceutical market reports are ideal for executives
wanting to understand the key drivers in pharmaceutical markets and have
access to a wealth of statistical data. Each report opens with an
outlook section that provides analysis of the market, 5-year market
forecasts, national data projections, market outlook and key
developments such as regulation, pricing/reimbursement, intellectual
property, health facilities and government policy.
The report also provides extensive background information, population
trends, health status, health expenditure, organisation &
administration, hospital services, medical personnel, healthcare
development, market access information, trade data for raw materials and
finished products and essential industry contacts. Included with the
report are 3 free quarterly updated outlook reports, enabling you to
keep up to date with market developments for a year.
Key Topics Covered:
1. Executive Summary
2. Introduction
3. Current market size
5. Generic usage
6. OTC market
7. Market projections & outlook
8. Imports
9. Domestic manufacturing
10. Multinational Manufacturing
11. Exports
12. Research & development
13. Pharmaceutical regulations
14. Pricing & reimbursement
15. Intellectual property
16. Distribution & retail
17. Demographics
18. Healthcare system
19. Health expenditure
20. Healthcare infrastructure
21. Healthcare personnel
22. Directory
23. Methodology & sources
97. Appendix: healthcare statistics
Companies Mentioned:
Pharmaniaga
Zuellig Pharma
Apex Healthcare Berhad
For more information visit http://www.researchandmarkets.com/research/b4283a/the_pharmaceutical
Source: Espicom Business Intelligence Ltd
Contact:Research and MarketsLaura WoodSenior Managerpress@researchandmarkets.comFax
from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716
Next Article: Research and Markets: Malaysian Commercial Banking Report Q2 2009 Report - Independent Forecasts and Competitive Intelligence
Previous article: Research and Markets: Malaysia Oil and Gas Exploration and Production Industry Investment Opportunities, Analysis and Forecasts to 2013
Top Headlines
Australian business confidence soars: survey
Thursday June 18, 07:38 PM - AFP Business News
SYDNEY (AFP) - Australian business confidence posted its largest quarterly jump for more than 30 years in the three months to .. Read More
NZ sharemarket closes higher
Thursday June 18, 06:58 PM - NZPA
The New Zealand sharemarket put runs on the board against the run of play in Asian markets, mostly due to strength in Telecom .. Read More
TSB Bank cuts two-year fixed home loan rate
Thursday June 18, 06:55 PM - NZPA
TSB Bank is cutting its two-year fixed home loan rate to 5.99 percent to stimulate demand for home loans. .. Read More
Calculators
Copyright © 2009 Yahoo! All rights reserved.
Yahoo!Xtra: A Yahoo!7/Telecom New Zealand Company.